Labixiaoxin Snacks Group Limited announced the completion of its discloseable transaction to acquire the Target Company on 31 March 2026. All conditions precedent under the Sale and Purchase Agreement have been met, enabling the issuance of both consideration shares and a convertible bond under the company’s general mandate.

Following completion, the Target Company is now a wholly owned subsidiary of Labixiaoxin. Consequently, the Target Company’s financial results will be fully consolidated into the Group’s financial statements, expanding Labixiaoxin’s operational scope and earnings base.

The transaction milestones were previously outlined in announcements dated 5 February 2026 and 18 March 2026. Shenwan Hongyuan Capital (H.K.) Limited served as the financial adviser for the deal.